Financial Health Assessment: QUANTUM PROFILE SYSTEMS LIMITED

1. Financial Health Score: B

Explanation: The company receives a strong 'B' grade, indicating a generally healthy financial constitution with a few areas requiring monitoring. The business has successfully recovered from a loss-making year, demonstrating underlying resilience and improved metabolic efficiency (gross margins). However, a slight contraction in revenue (turnover), aggressive dividend extractions that exceed net profits, and relatively low immediate cash reserves prevent a higher rating. The patient is healthy but needs to manage its circulation (cash flow) carefully to avoid future strain.

2. Key Vital Signs

• Revenue (Metabolic Rate): £12.54m (Down 6.2%) The company's metabolic rate has slowed slightly, with turnover decreasing from £13.37m in 2023 to £12.54m in 2024. While not drastic, this indicates a mild reduction in overall business activity or market demand.
• Profitability (Blood Pressure): Pre-tax Profit of £130,173 Excellent recovery here. After suffering a loss of £92k in 2023, the company has returned to the black. Underlying profits before £123k of restructuring costs were a healthier £253k. The gross margin improved significantly (from roughly 37.8% to 42%), suggesting the "treatment" for stabilizing material and energy costs has been effective.
• Liquidity (Circulation & Hydration): Current Ratio of 1.63 Current assets (£5.04m) comfortably exceed current liabilities (£3.09m), meaning the company can easily meet its short-term debts. However, cash at bank (£53.5k) remains quite low relative to the size of the business, meaning a significant portion of its "blood" is tied up in debtors (£4.48m) rather than readily available.
• Solvency (Structural Integrity): Net Assets of £2.59m The company has a strong skeletal structure. Net assets have grown substantially over the long term (from £1.02m in 2016 to £2.59m in 2024), though they dipped slightly from £2.71m in 2023. This minor drop is directly attributable to dividend payments exceeding the year's net profit.
• Dividend Payout (Bleeding): £181,000 The company paid out £181k in ordinary dividends despite a net profit for the year of only £65.7k. This means the business bled more cash to its shareholders than it internally generated, drawing down on its retained reserves.

3. Diagnosis

Overall Condition: Stable, but showing signs of parental strain.

Quantum Profile Systems has undergone a successful course of treatment. The 2023 financial year showed symptoms of distress—a pre-tax loss of £92k driven by inflated material and energy costs. In 2024, the management implemented a restructuring protocol (costing £123k) and successfully stabilized input costs, returning the underlying operating body to health.

However, looking at the circulatory system, we see a classic symptom of a subsidiary company serving a parent entity. The parent company (Quantum Lean Solutions Limited, owning >75%) extracted £181k in dividends. Because this exceeded the £65.7k net profit, the company's retained earnings and net assets actually shrank. While the company's structural reserves are robust enough to handle this currently, consistently extracting more than the business generates will gradually weaken the patient's financial immune system over time.

Furthermore, the balance sheet shows an excessive concentration of weight in debtors (£4.48m out of £5.04m in current assets). This suggests that cash is circulating very slowly—stuck in the arteries rather than flowing through the system. If a major debtor were to default, it could cause a sudden and severe cash flow crisis, especially with only £53k in the bank.

4. Recommendations

1. Improve Circulation (Debtors Management): With £4.48m tied up in debtors, the priority must be to accelerate cash collection. Implement stricter credit control protocols and consider offering early payment discounts to customers. Moving cash from the "debtors" column to the "bank" column will dramatically improve the company's immediate financial hydration and resilience.
2. Monitor the Dividend "Bleed": While the company has ample reserves to cover the current dividend payout, extracting more cash than the business generates in profit is not sustainable long-term. It is recommended that future dividend policies align more closely with net profit generation to ensure the company retains enough nutrients to fund its own growth and protect against future economic shocks.
3. Maintain the Current Diet (Cost Control): The stabilization of material and energy costs has been the key to returning to profitability. Continue to use forward-buying and fixed-price negotiations for key raw materials (especially those traded in dollars and euros) to immunize the business against macroeconomic volatility.
4. Build an Emergency Cash Reserve: Aim to build the cash-at-bank balance to at least 2-3 months of operating expenses. This will serve as a vital financial immune booster, ensuring the business can weather any future disruptions without needing external financing.